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Summary 
Mass spectrometry in combination with liquid chromatography (LC-MS/MS) 
has emerged as the method of choice for the identification and quantification 
of protein sample mixtures. For very complex samples such as complete 
proteomes, the most commonly used LC-MS/MS method, data dependent 
(DDA) precursor selection, is of limited utility. The limited scan speed of 
current mass spectrometers, along with the highly redundant selection of the 
most intense precursor ions generate a bias in the pool of identified proteins 
towards those of higher abundance. A directed LC-MS/MS approach that 
alleviates the limitations of DDA precursor ion selection by decoupling peak 
detection and sequencing of selected precursor ions is presented. In the first 
stage of the strategy, all detectable peptide ion signals are extracted from 
high resolution LC-MS feature maps or aligned sets of feature maps. The 
selected features or a subset thereof are subsequently sequenced in 
sequential, non-redundant directed LC-MS/MS experiments and the MS/MS 
data are mapped back to the original LC-MS feature map in a fully automated 
manner. The strategy, implemented on a LTQ-FT MS platform, allowed the 
specific sequencing of 2,000 features per analysis and enabled the 
identification of more than 1,600 phosphorylation sites using a single reversed 
phase separation dimension without the need for time consuming pre-fraction 
steps. Compared to conventional DDA LC-MS/MS experiments, a 
substantially higher number of peptides could be identified from a sample and 
this increase was more pronounced for low intensity precursor ions. 
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Introduction 
Over the past decade, mass spectrometry (MS) has emerged as the method 
of choice for the identification and quantification of proteins in very complex 
biological samples (1). In the most widely used implementation, referred to as 
shotgun proteomics, protein samples are first digested, the resulting peptide 
mixtures are then chromatographically separated and finally sequenced by 
automated tandem mass spectrometry (MS/MS). Due to its conceptual and 
experimental simplicity, the shotgun approach has become a very popular 
method for the identification of proteins in a wide range of biological samples 
and, in combination with stable isotope labeling, also for quantitative 
proteomic studies (2-4). Recent technical improvements in MS 
instrumentation, database searching and result validation as well as advances 
in database annotation now make it possible to routinely identify hundreds to 
a few thousand of proteins in complex biological samples (5-8).  
Despite this impressive progress, shotgun proteomics is not yet capable of 
characterizing whole proteomes and presents obvious biases, among them 
the discrimination against protein species of low abundance (5, 8). This is 
primarily a consequence of limited sequencing speed of current LC-ESI-
MS/MS systems that are incapable of analyzing each precursor ion detected 
in complex samples together with the redundant selection of a subset of 
precursor ions, even if precautions like dynamic exclusion are applied. 
Therefore, even in repeat analyses of the same sample exhaustive 
identification of the low intensity precursors is not achieved (9-11).  
In contrast to these approaches based on data dependent precursor ion 
selection (DDA), directed peptide sequencing provides the advantage of 
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focusing the MS/MS-analysis on non-redundant and information rich 
precursor ions, thereby better managing the analysis time and increasing 
depth of analysis (12, 13). In this regard, a two stage strategy by which all 
MS1 features that represent peptides are extracted from LC-MS maps and 
subsequently subjected to targeted sequencing, in principle, should lead to 
the identification of all detectable precursors (14). Since the acquisition of 
MS1 and MS2 spectra is naturally decoupled in MALDI-MS/MS, this platform 
is well suited for directed sequencing and has been applied to selectively 
analyze differential expression or modifications of proteins (15, 16).  
The same principle is also applicable to ESI-MS, which has the potential to 
provide much higher sequencing speed in routine applications compared to 
MALDI-MS/MS. Since the peptides are not “immobilized” on the sample plate, 
repeat injections of the same sample are required, the first to detect the MS1 
features and subsequent ones for directed sequencing. Naturally, the 
decoupling of feature detection and sequencing demands highly reproducible 
elution times and high mass accuracy. A directed sequencing strategy has 
been already applied on high mass accuracy ESI instruments to specifically 
sequence peptides of single proteins in complex mixtures (17) and for the 
detection of low-abundant peptide species (18). However, the number of 
targeted peptide ion masses was limited to a few hundred per run, a much 
lower number of sequencing attempts than modern ESI-MS/MS instruments 
are capable of performing in DDA mode. The number of targeted precursors 
could only be increased by sample and time-consuming multiple LC-MS/MS 
analyses of the same mixture. 
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In the present study, a high performance LTQ-FT-ICR mass spectrometer that 
allows segmentation of inclusion mass lists by LC elution time was used for 
directed sequencing. Each inclusion lists contained the mass-to-charge ratio 
(m/z) and elution time of the targeted precursors and was divided into 
segments of 3 to 5 minutes, thereby increasing the number of possible target 
masses to 3,000 in a one-hour LC gradient. The strategy was supported by 
software tools to i) automatically extract peptide features from MS1 maps and 
to align features over multiple LC-MS/MS patterns (13), ii) generate inclusion 
lists from the identified features (19), iii) control directed sequencing of the 
features on the inclusion list by sequential LC-MS/MS analyses of the same 
sample and iv) to map the MS/MS data obtained back to the initial feature list. 
The potential of the directed MS/MS approach was evaluated by in-depth 
characterization of complex peptide and phosphopeptide mixtures obtained 
from D. melanogaster lysates. The data demonstrated the high specificity and 
reproducibility of the method to identify a higher number of peptides from the 
same sample in a lower number of LC-MS/MS runs compared to standard 
DDA LC-MS/MS analysis, specifically in the class of low intensity precursor 
ions. 
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Material and Methods 
 
Cell culture and phosphopeptide enrichment  
All chemicals, if not otherwise mentioned, were bought at the highest 
available purity from Sigma-Aldrich, Taufkirchen, Germany. 
Cell culture, lysis and protein digestion 
D. melanogaster Kc167 cells were grown in Schneiders Drosophila medium 
(Invitrogen, Auckland, New Zealand) supplemented with 10 % fetal calf 
serum, 100U penicillin (Invitrogen, Auckland, New Zealand) and 100 µg/ml 
streptomycin (Invitrogen, Auckland, New Zealand) in an incubator at 25 °C. In 
order to increase the degree of phosphorylation in the Drosophila proteins 
different batches of cells were pooled which were either growing in rich 
medium, serum starved medium, treated for 30 min with 100 nM Rapamycin 
(LClabs, Woburn, MA, USA), treated for 30 min with 100 nM insulin or treated 
for 30 min with 100 nM Calyculin A. Then the cells were washed with ice cold 
phosphate buffered saline (PBS) and re-suspended in ice cold lysis buffer 
containing 10 mM HEPES, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM 
dithiothreitol (DTT) and a protease inhibitor mix (Roche, Basel, Switzerland). 
In order to preserve protein phosphorylation, several phosphatase inhibitors 
were added to a final concentration of 20 nM calyculin A, 200 nM okadaic 
acid, 4.8 µm cypermethrin (all bought from Merck KGaA, Darmstadt, 
Germany), 2 mM vanadate, 10 mM sodium pyrophosphate, 10 mM NaF and 5 
mM EDTA, respectively. After 10 min incubation on ice, cells were lysed by 
douncing. Cell debris and nuclei were removed by centrifugation for 10 min at 
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4 °C using 5,500 xg. Then the cytoplasmic and membrane fraction were 
separated by ultracentrifugation at 100,000 xg for 60 min at 4 °C. The proteins 
of the cytosolic fraction (supernatant) was subjected to acetone precipitation. 
The protein pellets were re-solubilized in 3 mM EDTA, 20 mM TrisHCl pH 8.3 
and 8 M urea. The disulfide bonds of the proteins were reduced with tris(2-
carboxyethyl)phosphine (TCEP) at a final concentration of 12.5 mM at 37 oC 
for 1 h. The produced free thiols were alkylated with 40 mM iodoacetamide at 
room temperature for 1 h. The solution was diluted with 20 mM TrisHCl (pH 
8.3) to a final concentration of 1.0 M urea and digested with sequencing-grade 
modified trypsin (Promega, Madison, Wisconsin) at 20 g per mg of protein 
overnight at 37oC. Peptides were desalted on a C18 Sep-Pak cartridge 
(Waters, Milford, Massachusetts) and dried in a speedvac. Finally, 1 g of 
peptide sample was utilized for each LC-MS/MS experiment.  
 
Phosphopeptide isolation 
Phosphopeptides were isolated using TiO2 affinity enrichment as recently 
described (20). 1 g of the phosphopeptide sample was subjected to each 
LC-MS/MS analysis. 
Reverse phase HPLC 
Peptide samples were analyzed on an Agilent 1100 microflow system (Agilent 
Technologies) connected to a 7 tesla Finnigan LTQ-FT-ICR instrument 
(Thermo Electron, Bremen, Germany) equipped with a nanoelectrospray ion 
source (Thermo Electron, Bremen, Germany). Peptides were separated on a 
RP-HPLC column (150 m x 15 cm) packed in-house with C18 resin (Magic 
C18 AQ 5 μm; Michrom BioResources, Auburn, CA, USA) using a linear 
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gradient from 98 % solvent A (0.15 % formic acid) and 2 % solvent B (98 % 
acetonitrile, 2 % water, 0.15 % formic acid) to 30 % solvent B over 60 minutes 
(for cytosol digest) and 90 minutes (for phosphopeptide enriched samples) at 
a flow rate of 1.2 l / min. 
 
Mass spectrometry 
In DDA mode, each MS1 scan (acquired in the ICR cell) was followed by 
collision induced dissociation (CID, acquired in the LTQ part) of the three (for 
feature extraction) and five (for comparison of DDA and directed LC-MS/MS) 
most abundant precursor ions with dynamic exclusion for 30 seconds. Only 
MS1 signals exceeding 150 counts were allowed to trigger MS2 scans with 
wideband activation enabled. Total cycle time was approximately 1 to 1.5 s. 
For MS1, 106 ions were accumulated in the ICR cell over a maximum time of 
500 ms and scanned at a resolution of 100,000 FWHM (at 400 m/z). MS2 and 
MS3 spectra were acquired using the normal scan mode, a target setting of 
104 ions and accumulation time of 250 ms. Singly charged ions and ions with 
unassigned charge state were excluded from triggering MS2 events. The 
normalized collision energy was set to 30%, and one microscan was acquired 
for each spectrum. For phosphopeptide analysis, the mass spectrometer 
automatically switched between MS, MS2, and neutral loss-dependent MS3 
acquisition. Data-dependent settings were chosen to trigger an MS3 scan 
when a neutral loss of 97.97, 48.99, 32.66, 24.5 or 19.6 Da was detected 
among the ten most intense fragment ions.  
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Peak detection 
First, the data of the initial three LC-MS (mapping) runs (raw format) was 
converted to the profile mzXML format (21). Then, the in-house developed 
software system SuperHirn (22) was used for i) detection, ii) de-isotoping, iii) 
peak integration and iv) alignment of detected features over multiple LC/MS 
patterns. Peak intensities were measured by calculating peak areas from 
extracted ion chromatograms (XICs) of each MS signal. Highly stringent 
criteria were applied to filter the detected peaks for peptide signals. 
Specifically, the algorithm searches for peaks patterns matching isotope 
distributions typical for peptides within the m/z value range under 
investigation. Peaks had to be detected in at least two subsequent MS1 scans 
and with a minimum of three isotopic peaks to be considered. Only peaks that 
could be found in at least two LC-MS runs were considered and singly 
charged masses were excluded. Finally, a list of the relevant features was 
generated and used to build mass inclusion lists for directed MS-sequencing.    
 
Generation of inclusion lists  
To make the generation of inclusion lists less time consuming, less prone to 
human error and easier to reproduce we developed the “Inclusion List Builder” 
software. The Inclusion List Builder has a rich graphical user interface and is 
implemented as a plug-in for the Prequips platform (19) (Download: 
http://tools.proteomecenter.org/wiki/index.php?title=Software:Prequips:Inclusi
on_List_Builder). 
The table containing all features extracted from initial LC-MS runs is imported 
through the Prequips’ data provider interface and converted into a so-called 
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“Master Table” by the Inclusion List Builder. The master table contains the m/z 
ratios, retention times, averaged peak areas and charge states for all features 
identified by the SuperHirn algorithm. Through interactive application of filters 
to feature attributes inclusion lists are created as subsets of the master table 
and segmented by retention time. This is necessary, since the number of 
features present in the table usually exceeds the number of possible 
sequencing cycles that the mass spectrometer can acquire in a single run. 
After segmentation the inclusion lists are exported as tables (.csv file format) 
that can be read by the MS-instrument software. 
In the study presented here, the following software settings were used for the 
directed analysis of the peptide mixtures. The 9,680 features extracted from 
the three map runs analyzing the drosophila lysate digest were split by their 
intensity into five bins, each consisting of 2,000 masses (1,680 for the last bin 
containing the least intense features) using the following average peak area 
thresholds; very high: 2.6x109 – 3x107, high: 3.0 – 1.4x107, medium: 1.4x107 - 
8.1x106, low: 8.1 – 4.9x106, very low: 4.9x106 – 5.3x105. Each subset was 
further clustered into 3 or 5-minute segments using the following elution time 
values (in minutes); 0 - 27.5 - 32.5 - 37.5 - 40.5 - 43.5 - 46.5 - 49.5 - 52.5 - 
55.5 - 58.5 - 61.5 - 66.5 - 71.5 - 80. The start and stop time of each 5 (3) 
minute time segment was extended by 2.4 (1.4) and 2.5 (1.5) minutes, 
respectively, to compensate for variations in retention time. Since the 
instrument software requires a few seconds to load/delete the new/old 
masses in each time segment, a delay of six seconds was implemented for 
each start time. For directed analysis of the phosphopeptide-enriched sample 
(90 minute gradient), the features were clustered using the following elution 
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time bins: 0 - 22.5 - 27.5 - 32.5 - 37.5 - 42.5 - 47.5 - 52.5 - 57.5 - 62.5 - 67.5 - 
72.5 - 77.5 - 82.5 - 87.5 - 95 - 110. In summary, this setup allowed, assuming 
equal distribution, the inclusion of up to 3,000 features in a single directed LC-
MS/MS analysis using a 60 minute gradient. It is important to note that 
applying shorter time segments could further increase this number. 
 
Directed MS-sequencing of features 
The generated inclusion lists (.csv file format) were directly imported into the 
global mass list parent ion table of the MS operating software (XCalibur 2.0 
SR 1, Thermo Electron, Bremen, Germany) and activated. Basically, the 
settings for targeted LC-MS/MS were similar to those described above with a 
few modifications. First, the dynamic exclusion mass window that is also 
setting the m/z tolerance for the inclusion list masses was narrowed to ±10 
ppm for all directed analyses with enabled monoisotopic precursor selection 
and to ±5 ppm when this option was turned off. Ion signals for which no 
charge could be assigned were also allowed to trigger MS2 scans. The 
dynamic exclusion time was reduced to 10 seconds to acquire multiple MS2 
scans for each feature. For directed sequencing in preview off mode, this 
option was disabled and the resolution of the MS1 scan in the ICR cell 
reduced to 50,000. For sequencing low abundant features of low abundance, 
the monoisotopic precursor selection option was disabled and, to minimize 
unspecific sequencing, the threshold required for triggering MS2 events was 
raised from 150 to 3,000 counts. 
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Database searching 
All acquired MS2 and MS3 spectra were searched against the Drosophila 
Flybase protein database (D. melanogaster, release 4.3; Mar 2006; 19645 
entries) that also contained the protein sequence of bovine trypsin and human 
keratins, using the Bioworks (Version 3.2) software (Thermo Electron, San 
Jose, CA). The search criteria were as follows: full tryptic specificity was 
required (cleavage after lysine or arginine residues, unless followed by 
proline); 2 missed cleavages were allowed; carbamidomethylation (C) was set 
as fixed modification; oxidation (M) and, if required, phosphorylation (STY) 
were applied as variable modifications; mass tolerance of the precursor ion 
and the fragment ions was 10 ppm and 0.8 Da, respectively. In addition to 
this, each data set was searched against a decoy Flybase protein database 
(Version 4.3), as described previously to assess the number of false positive 
peptide identifications (23). Based on this approach, the error rate was set to 
a maximum of 1% (error rate = 2 x percentage of decoy hits) using the 
following thresholds: Peptide probability (prob) < 0.01; Final score (Sf) > 0.2 
for unphosphorylated and > 0.4 for phosphorylated peptides. For each peptide 
sequence identified, all matching gene numbers (Flybase gene ID (FBgn)) 
and protein accession entries (Computed gene (CG)) were determined and 
displayed. In addition to this, Occam’s Razor logic as implemented in Protein 
Prophet (24) was applied to calculate the number of identified proteins (CG 
entries). In brief, redundant protein entries were removed by clustering 
peptides matching to multiple members of a protein family to a single protein 
group and considered as a single identification. Furthermore, when multiple 
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proteins shared a peptide sequence, it was only assigned to the protein 
identified with the highest number of peptide assignments. In-house software 
was used for the calculation of non-redundant phosphorylation sites present in 
the data sets obtained as recently reported (25). 
For comprehensive intensity comparison of the peptides identified by DDA 
and directed LC-MS/MS analysis (Figure 3B), the MS1 signal intensities were 
determined using the Bioworks software, to also include peptides exclusively 
identified in DDA mode. Therefore, the peak height of every single peptide 
precursor ion was determined by applying the following parameter: mass 
range of 0.03 Da; intensity threshold of minimal 1,000 and 3 smoothing points 
allowed. The intensity of the same peptide ions detected in multiple runs was 
averaged.  
 
Assignment of identified peptides to inclusion lists 
An Excel table (in tab-delimited format) containing the search results from the 
directed LC-MS/MS runs was imported into the Prequips software. Spectral 
data in mzXML format was loaded to obtain access to the corresponding 
retention times. All identified peptides were mapped to one or more features 
in the master table through the MS2 scans associated with them. 
For the mapping algorithm we define a scan as the triple (corrected retention 
time t’R, feature at mass m and charge z), where the feature mass m is 
defined as 
m = (precursor neutral mass + (z * 1.00727)) / z 
and the corrected retention time t’R is computed as 
t’R = a * tR + b 
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from the measured retention time tR. Since all LC-MS/MS experiments were 
performed using the same C18 column resulting in minimal shifts in feature 
elution times, no corrections of tR were required. Therefore, a was set to 1 and 
the value for b was set 0. The following algorithm was applied for each 
identified peptide p: 
 
1) For every scan s associated with p find all features f in the master table that 
fulfill each of the following conditions: 
t’R(s) -   t’R(f)  t’R(s) +  
m(s) -   m(f)  m(s) +  
z(s) = z(f) 
The retention time tolerance  (in minutes) and the mass tolerance  (in ppm) 
define windows of 2  and 2  centered on t’R(s) and m(s), respectively.  
2) Map p to all f fulfilling the conditions. 
 
A single peptide can be mapped to the same feature multiple times if it is 
associated with more than one scan. Also, more than one distinct peptide can 
be mapped to a feature. The peptide with the lowest retention time and mass 
difference is automatically selected as the best hit. The investigator can 
manually assign any other of the peptides mapped as the best hit for a given 
feature if there is supporting evidence. 
For mapping back identified features to the initial inclusion list, the theoretical 
m/z values and the elution time of the identified peptides was matched with 
the precursor masses and elution times in the inclusion list. A mass tolerance 
of 0.01 Da and a time tolerance of 1 minute were allowed. Since no pre-
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column was used during LC, very hydrophilic peptides, which were not or only 
partially retained by the C18 resin, showed very inconsistent retention times. 
Therefore, all peptides having LC retention times of less than 30 minutes were 
matched only by their m/z and charge values.  
 
Results 
 
The directed precursor ion selection workflow 
The general workflow of the directed LC-MS/MS analysis described in this 
manuscript is outlined in Figure 1. It consists of the following steps: 
(1. Sample preparation) The proteins in a sample obtained from any source 
(cells, tissue, body fluids, etc.) are reduced, alkylated and enzymatically 
cleaved with trypsin.  
(2. Feature detection) Sample aliquots are then analyzed by high performance 
LC-MS/MS whereby the MS1 features are recorded and selected precursor 
ions are picked for CID by DDA. Usually, we performed three independent 
LC-MS/MS runs, each consuming 1 g of total peptide mass. The data 
obtained is subsequently analyzed offline by the in-house software tool 
SuperHirn (13) that automatically extracts all detectable MS1 signals from the 
individual LC-MS patterns by applying peak detection, noise reduction, de-
isotoping and intensity determination algorithms to each detected peak. The 
detected ions are then aligned within the respective patterns. 
(3. Master table generation) The software overlays over all detected peaks an 
isotope distribution template that is typical for peptides, thereby discriminating 
between peptide and contaminant signals, and finally generates a master 
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table of all masses that are very likely to be peptide ions. Each of these 
features is described by its m/z ratio, charge state, intensity and 
chromatographic retention time. All features are then imported into a second 
in-house software tool, Prequips that supports data filtering, generation of 
inclusion list files and mapping MS2 data back to the respective MS1 features 
in an automated manner (19). The alignment of features over multiple 
patterns was a very effective method to reduce noise or signals from non-
peptidic material if only MS1 signals that are found in at least two of the three 
replicate LC-MS runs were considered for further analysis. In the end, around 
10,000 features are detected in a typical experiment.  
(4. Inclusion list creation) Since for most samples the number of features 
detected exceeded the number of available sequencing cycles, the feature list 
was further divided according to the sequencing speed of the MS instrument 
used. For the LTQ-FT-ICR instrument employed in our study, a list of 10,000 
features was divided into five LC-MS/MS inclusion lists of 2,000 features 
each. In general, the features were grouped into segments of five (three for 
highly populated areas) minutes and flanked by 2.5 (1.5) minutes extra time, 
respectively, resulting in segments of 10 (6) minutes, respectively. Hence, 
each feature could tolerate a shift in retention time during LC of at least 2.5 
(1.5) minutes. Initial tests showed that the current instrument control software 
(Xcalibur 2.0 SR1) limited the number of ions on an inclusion list to a 
maximum of 500. Thus the construction of the inclusion list required that the 
number of features from two overlapping segments did not exceed 500. 
Besides, the lower number of features early and late in the gradient allowed 
the generation of longer segments with a higher time tolerance in those 
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regions. The long time segment at the beginning is essential for targeting 
hydrophilic peptides, because these molecules do not, or only weakly, bind to 
the RP-LC column and consequently showed considerable shifts in elution 
times between different runs. For samples that showed a common feature 
distribution, a maximum of 3,000 features could be sequenced per hour (~ 1 
feature / sec). It is worth mentioning that this number could be further 
increased by a further reduction of the time segments. 
(5. Feature identification) The MS2 data obtained from the directed LC-
MS/MS analyses was searched against protein databases and, together with 
the corresponding mzXML files, mapped back to the master table using the 
Prequips software. 
 
Reproducibility of LC-MS 
The success of an inclusion list experiment strongly depended on the 
reproducibility of both, LC and MS performances. Figure S1 shows that 
variations in retention time were below 20 seconds and mass accuracy was 
better than 2 ppm. These variations are well within the time and m/z 
tolerances of 2.5 minutes and 10 ppm, respectively, used for directed MS2. 
Naturally, the time and m/z tolerances should be kept as small as possible to 
minimize random MS-sequencing events. 
 
Optimization of MS-parameters for improved identification of features 
To optimize the number of features identified in a targeted precursor ion 
selection experiment we generated a peptide mixture from D. melanogaster 
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Kc167 cells and subjected aliquots to repeat analyses in which relevant 
experimental parameters were varied.  
Cells (108) were harvested, disrupted and the cytosolic fraction was isolated. 
The proteins were alkylated, trypsinized and three aliquots, each containing 
1 g of peptides, were analyzed as described above (Figure 1). A total of 
9,680 unique features could be detected (see Table S3) that were imported 
into the master table. The features were grouped by decreasing intensity into 
five inclusion lists each containing around 2,000 features, and subjected to 
directed LC-MS/MS analysis.  
Subsequently, the influence of two important parameters for triggering MS2 in 
the LTQ-FT MS employed, the preview mode and the monoisotopic precursor 
selection (MPS), respectively, was evaluated. With preview mode on (default 
mode), the instrument acquires a low resolution MS1 spectrum (pre-scan) that 
takes around 20% of the total scan time and continues scanning the ions for 
high resolution while the LTQ is performing MS2 scans of selected ions in 
parallel (Figure 2C). This significantly increases MS2 scan rates but peptide 
ions for MS2 are selected from low resolution MS1 scans. By disabling the 
preview mode and reducing the resolution to 50,000 for MS1, the mass 
accuracy of the peptide ions selected online for directed MS2 could be 
improved. Consequently, 8% (13%) more features were identified 
(sequenced) from the Kc167 cell sample from the five inclusion lists with 
preview mode disabled (Figure 2A, Table S1, S4, S5). Despite the slightly 
longer cycle times required (Figure 2D), the speed of the MS instrument used 
was still sufficient to selectively sequence up to 2,000 features in a 60 minute 
gradient (Table S1). It is important to note that the improvements were 
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particularly pronounced for features with lower intensities. Additionally, the 
MS2 selection efficiency of peptide ions of low abundance could be further 
improved by disabling MPS, which makes every single isotopic peak in the 
MS1 scans accessible for triggering MS2. As a consequence, the yield of 
identified low abundant peptide signals could be further improved from 33% to 
40% and 26% to 35% for low and very low intense features, respectively 
(Figure 2A).  
It is worth mentioning that increasing the number of ions into the ICR-cell for 
MS1 scans also slightly increased the numbers of identified low abundance 
ions, however, to a lower extend than by the disabling MPS (data not shown). 
This is due to the fact that high ion numbers in the ICR-cell lead to space 
charge effects that lower peptide mass accuracy (26, 27). Therefore, some 
features might fall out of the m/z tolerances applied and would not be 
sequenced if the ICR cell is filled with a high number of ions.  
 
Using the optimized MS-parameters, around 80% of all detected features 
were selected for sequencing and 48% of those could be confidently 
identified, resulting in the identification of 3,931 unique peptides and 793 non-
redundant gene products (Table S1+S6). In addition, the occurrence of 
random sequencing of MS-signals not selected for directed MS2 was very low 
since only about 11.6% (516) of all identified peptides in the five inclusion list 
runs could not be mapped back to the master feature list. This demonstrates 
that the whole process starting with feature extraction from high resolution 
MS1 maps followed by directed sequencing using an inclusion list protocol 
and mapping back the MS2 data to the features is very effective and specific. 
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Comparison of data dependent and directed LC-MS/MS 
To assess the performance of the directed LC-MS/MS approach in 
comparison to CID experiments using DDA, we compared the data obtained 
from applying the protocols optimized as described above with the results of 
five repeat LC-MS/MS runs using DDA. The sample was a tryptic digest of 
Kc167 cell cytosolic fraction and in each analysis 1 g of total peptide mass 
was injected. To increase the number of MS2 spectra acquired, the 
instrument was programmed to randomly select for CID the five most intense 
precursor ion signals detected in a survey scan in the LC-MS/MS experiment 
with DDA and the peptides identified by either strategy were compared.  
As shown in Figure 3A (blue line), 2,493 unique peptides were identified in the 
first DDA LC-MS/MS run, but then the contribution of additional LC-MS/MS 
runs of the same sample to the overall number of peptides was decreasing 
rapidly, eventually identifying only 1,083 (43.4%) additional peptides in the 
four subsequent LC-MS/MS runs (Table S2+S7). This effect was even more 
apparent at the protein level where only 111 (21.0%) new gene products 
could be discovered by the additional four LC-MS/MS experiments. Notably, 
the number of identified peptides over all five DDA runs was highly consistent, 
ranging from 2,461 - 2,493 (Table S2+S7). This clearly demonstrates a strong 
sequencing redundancy in shotgun LC-MS/MS, which is in agreement with 
observations obtained from other recent studies (9-11).  
In contrast, the directed approach presented here allowed the non-redundant 
sequencing of every single feature in only one LC-MS/MS run and therefore, 
the degree of novel peptide identifications in each analysis was much higher, 
22 
 
resulting in a much steeper curve (Figure 3A, orange line). Here, using the 
optimized MS-parameters shown above (Preview mode and MPS disabled, 
Figure 2), 2,746 (237%) additional peptides could be determined after the first 
directed LC-MS/MS run resulting in a total of 3,931 unique peptide 
identifications. Using non-redundant sequencing also allowed the 
identification of a significant number of additional proteins in each directed run 
compared to DDA LC-MS/MS (Table S1). Eventually, a higher number of 
peptides and proteins were identified in five directed runs than in five DDA 
LC-MS/MS analyses, despite the much lower number of sequencing events, 
clearly indicating the higher information content of the ions extracted offline 
over DDA LC-MS/MS (Table S1 + S2). Interestingly, the INL curve (Figure 3A) 
is only slightly flattening with decreased feature signal intensity, which 
suggests that potentially even more peptides can be identified by the directed 
approach if less stringent peak picking criteria would be applied and additional 
inclusion list runs would be carried out on the same sample.  
It is important to point out that current mass spectrometers offer possibilities 
to sequence additional low-abundant peptides in DDA mode (28). However, 
most of them drastically reduce the number of MS1 scans acquired, and 
therefore lower reliable quantification of complex peptide mixtures. 
Conversely, directed LC-MS/MS enables the identification of low-abundant 
peptides without affecting MS1 performance and thus quantification accuracy. 
 
Combination of DDA and directed LC-MS/MS 
As shown in Figure 3A, three inclusion lists were necessary to identify as 
many peptides/proteins as in a single DDA LC-MS/MS experiment. Therefore, 
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excluding already selected features from the initial LC-MS run for the 
generation of MS1 maps and specifically targeting the remaining features 
would be expected to reduce the number of directed LC-MS/MS runs required 
to sequence every detectable feature. We applied a combined strategy of two 
initial DDA runs with subsequent directed runs to the Kc167 cell sample 
described above. As shown in figure 3A, the results of more than 5,000 
sequencing attempts of the first two DDA LC-MS/MS analyses runs could be 
mapped back to the feature list, thereby reducing the number of features from 
9,680 to 4,323 that were specifically targeted in two additional LC-MS/MS 
experiments. The first directed run already identified as many novel peptides 
as the three additional DDA runs together and eventually, 4,273 unique 
peptides corresponding to 804 different proteins could be identified after only 
four LC-MS/MS runs (Figure 3A, green line, Table S8). In total, a higher 
number of peptides could be identified with less analytical effort and time by 
the combined approach than by the DDA or directed approach alone. Notably, 
the high performance hybrid LTQ-FT mass spectrometer used for our 
experiments is very well suited for the combined approach, since the ICR cell 
enables the acquisition of high resolution MS1 data while, in parallel, the LTQ 
part can collect MS2 data without sacrificing time, resolution or sensitivity for 
MS1 data acquisition (Figure 2C).  
 
To evaluate the intensity distribution of the peptides identified by both, DDA 
alone (Figure 3A, blue line) and in combination with directed (Figure 3A, 
green line) LC-MS/MS, the precursor ion abundances of these peptides were 
calculated and compared. To obtain an un-biased intensity determination of 
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all identified precursor ions, their base peak intensities were calculated using 
the Bioworks software tool. As shown in Figure 3B, most of the peptide ions 
identified in DDA mode had intensities between 106 and 2x106 counts (Figure 
3B, blue line). By contrast, the peak maximum of the distribution of peptides 
exclusively identified by the two inclusion list runs is clearly shifted towards 
precursor ions with lower abundance. The apex of the distribution of the 
peptides determined by the inclusion list in the combined approach was 
around 2x105 to 4x105 and thus about 5-times less intense than that of the 
DDA alone strategy (Figure 3B, red line). In combination with the data 
obtained from the first two DDA runs, the intensity of peptides determined by 
the combined approach was much less biased towards high abundant signals 
and more equally distributed (Figure 3B, green line). This clearly indicates that 
in complex peptide mixtures, a higher number of peptide ions with low 
intensities could be identified by directed than by DDA LC-MS/MS 
approaches.  
 
Reproducibility of directed LC-MS/MS sequencing  
To evaluate the reproducibility of the directed approach for both, feature 
selection and identification, 200 identified features from each of the five 
intensity groups (very high to very low) were combined and re-analyzed five 
times. Overall, the selected features spanned more than three orders of 
magnitude in signal intensity. The data are shown in Table 1 and Figure S2 . 
Of the 1,000 features targeted, more than 85% did trigger sequence attempts 
and around 70% could be confidently identified in all five LC-MS/MS runs. 
Furthermore, of the 1,000 features on the respective inclusion list, 984 did 
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trigger a MS2 scan event and 945 could be assigned to the correct peptide 
sequence in at least one run. Since the directed approach requires each 
feature to be detected online, the selection of features for sequencing strongly 
depends on their signal intensity. Whereas all of the 200 features in the group 
with the highest signal intensities were selected for MS2 in all five repeat LC-
experiments, that number decreased to 148 (74%) in the group with the 
lowest signal intensities (Figure S2B). A similar trend was observable for the 
number of correctly identified peptides albeit with a steeper decline at lower 
feature intensities. However, the MS2 spectra obtained can be useful for side-
by-side comparison of correctly assigned spectra to confirm the feature 
identity (29), even if the spectral quality is not sufficient for the assignment of 
a peptide sequence by a database search engine.  
  
Directed analysis of a complex phosphopeptide mixture 
Phosphopeptides, specifically those phosphorylated at serine or threonine 
residues are notoriously difficult to identify, due to their specific fragmentation 
patterns in ion trap instruments.  
To evaluate the performance of directed sequencing for the identification of 
phosphopeptides we applied the combined directed approach described 
above (Figure 3A, green line) to a sample consisting of phosphopeptides 
isolated by TiO2 affinity chromatography (20, 30) from a cytosolic fraction of 
Kc167-cells. The sample was separated using a RP-LC gradient that was 
extended by 30 minutes compared to the one used for non-phosphorylated 
peptides to compensate for the longer MS acquisition times applied for 
phosphopeptide analysis (MS2 followed by MS3 of the neutral loss peak of 
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-98 Da corresponding to the loss of phosphate). To maximize the number of 
identified features for a specific number of LC-MS runs, the experiment was 
designed such that in every run a different set of peptides was selected. 
Specifically, the following protocol was applied: First, the sample was 
analyzed by DDA LC-MS/MS, selecting precursor ions at [M+2H]2+ in the first 
run and ions at charge states higher than [M+2H]2+ in the second run, 
respectively. Then, all MS1 peaks were extracted from the high resolution 
MS1 maps obtained in those first two runs and filtered as described above. A 
total of more than 7,776 features that aligned over both runs were detected 
(Table S9), about half of which were already sequenced by the two initial LC-
MS/MS runs and excluded from following directed LC-MS/MS. After 
generating a series of inclusion lists, the remaining 4,000 features were 
subjected to directed sequencing in two additional LC-MS/MS experiments. 
To further increase the number of detected phosphopeptides, the 2,000 most 
abundant features showing a neutral loss peak but could not be confidently 
assigned to a peptide sequence were re-analyzed in one additional LC-
MS/MS run using a different MS-sequencing method especially designed for 
phosphopeptide analysis (31).  
Every directed LC-MS/MS run identified a considerable number of previously 
unidentified peptides. In total, after five LC-MS/MS runs, more than 1,600 
phosphorylation sites could be identified (Table 2 + S10, Figure S3). 
Interestingly, 1,500 (87.2%) of the 1,721 identified peptides carried at least 
one phosphate group confirming a high specificity for phosphopeptides of the 
TiO2 affinity enrichment. Of the 1,628 phosphorylation events detected, the 
exact site of phosphorylation of 1,204 sites could be determined with a 
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probability of more than 90% ( CN >0.1) (32). The distribution of 
phosphorylated amino acids was similar to that in other studies (20, 33) with 
most sites found on serine (82.7%), followed by threonine (15.4%) and 
tyrosine (1.9%) residues. In addition to this, the majority of phosphopeptides 
identified contained one phospho group (92.1%) whereas only 110 (7.3%) and 
9 (0.6%) were phosphorylated on two or three different residues, respectively. 
More importantly, compared to the DDA runs, 65% additional protein 
phosphorylation sites were identified by the three directed LC-MS/MS runs 
(run 3-5) of which 107 were identified by re-analyzing features that showed a 
neutral-loss of phosphate (-98 Da) during CID (run 5). Compared to a single 
DDA LC-MS/MS analysis of this sample that detected a total of 720 
phosphorylation sites (Table S11), the directed strategy employed here 
enabled the identification of a 2.3-times higher number of phosphosites after 
five LC-MS/MS runs. Annotated spectra of all phosphopeptides identified by 
the directed approach and by the single DDA LC-MS/MS run are shown in the 
Supplementary Figures 4 and 5, respectively. 
The value of the additional information obtained with directed LC-MS/MS can 
be demonstrated by the increased protein phosphorylation coverage of the 
Wnt signaling pathway, which is implicated in the genesis of cancer (34, 35). 
Table 3 shows all 8 identified phosphoproteins and their 13 phosphorylation 
sites that could be assigned to this pathway using PANTHER (36). Whereas 5 
phosphoproteins and 7 phosphorylation sites could be detected by the two 
initial DDA LC-MS/MS analyses (1-2), the three following directed LC-MS/MS 
runs (3-5) exclusively detected 3 phosphoproteins and 6 phosphorylation sites 
that increased the overall coverage of the pathway by 60% and 85.7%, 
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respectively. For example, phosphorylation of ATP-dependent Helicase 
SWR1 (Gene name: CG5899) at serine 169, 172 and 841 could be 
determined with high confidence only by additional directed LC-MS/MS. Even 
though the precursor ion signal intensity for fragment ion spectra acquired by 
directed sequencing were generally lower than those of the DDA runs, their 
quality was high. For instance, the complete y-ion series, with the exception of 
y1 and y2, of the doubly phosphorylated peptide 
“K.DQVYDpSDDpSDSEMSTK.M” could be assigned from its fragment 
spectrum (Figure 4B). Interestingly, the precursor ion was not picked for 
fragmentation in the first two runs although it is only 5-times less abundant 
than the highest peak present in the corresponding MS1 spectrum (Figure 
4A). Obviously, the sequencing speed of the MS was not sufficient to acquire 
MS2 spectra from the high number of co-eluting peptide ion present in the 
MS1 spectrum. This agrees very well with our results obtained from the 
sample consisting of non-phosphorylated peptides (Figure 3B). 
 
Discussion 
 
This study describes a reproducible, sensitive and integrated computational 
and mass spectrometric method for directed sequencing of a high number of 
peptide ions within complex mixtures. In contrast to concomitant MS1 and 
MS2 data acquisition during DDA ESI LC-MS/MS, the directed approach 
described decouples MS1 and MS2 spectra collection. In a first step, potential 
peptide ion signals are extracted offline from the pattern generated in initial 
LC-MS/MS runs. For this task we developed the software tools SuperHirn and 
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Prequips. In a second step, such features were subjected to directed 
sequencing in subsequent LC-MS/MS runs and the identified features 
automatically mapped back to the list of previously detected features. As we 
make the software tools developed for this method publicly available and as it 
uses generic data formats (21, 24, 37) for which converters for various MS-
instruments are available 
(http://tools.proteomecenter.org/wiki/index.php?title=Formats:mzXML), the 
presented approach is applicable to any high performance MS platform that 
allows direct sequencing by inclusion list. It is important to point out that high 
resolution scans are required only for MS1 data acquisition and not for MS2 
sequencing. Notably, hybrid MS instruments, like the LTQ-FT used in this 
study are preferred, since they provide the unique advantage of parallel MS1 
and MS2 spectra acquisition. Therefore, MS2 data can already be obtained in 
the initial LC-MS/MS runs with minimal impairment of the speed and 
sensitivity for acquiring high quality MS1 maps. Compared to current DDA LC-
MS/MS, the described directed strategy provides several advantages.  
 
First, the offline feature extraction facilitates the identification of peptides with 
low intensity precursor ion signals. Whereas peak selection in DDA LC-
MS/MS analysis is based on one single MS1 scan, offline peptide ion 
detection allows summing up all isotopic signals of an eluting peptide ion. This 
simplifies the selection of potential peptide ions based on the distribution of 
isotopic clusters as well as the determination of charge state and 
monoisotopic precursor mass. Moreover, the alignment of detected peptide 
ions over multiple runs helps to distinguish between peptide derived signals 
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and chemical and electronic noise. This significantly improved the generation 
of a feature list with a high content of peptide ions. As shown above, the 
directed sequencing of these information rich features resulted in a higher 
number of unique peptides identified compared to online CID by DDA. It is 
worth mentioning that the number of MS2 scans acquired by the directed 
approach was 3-times lower than by DDA LC-MS/MS, which considerably 
reduced the efforts for subsequent data analysis. 
 
Second in directed LC-MS/MS, the CID parameters can be adjusted and 
optimized according to the feature properties. For instance, a higher number 
of very intense features could be identified in one LC-MS/MS experiment by 
applying shorter ion accumulation and scan times whereas longer gating and 
scan times were employed for low abundant peptide ions. It is important to 
point out that the directed approach offers the opportunity of re-analyzing all 
features that could not be assigned to a peptide sequence in the first analysis 
using optimized MS-parameters. As shown by the results obtained in this 
study, more than 100 additional phosphorylation sites were determined by 
iterative analysis of phosphopeptides that showed a neutral loss peak but 
could not be confidently identified on the basis of their MS2 or MS3 spectra 
using the multistage activation mode for MS/MS data acquisition (31). The 
application of optimized CID parameters for each feature not only allows for 
the identification of more peptides but can also be employed to confirm 
peptide ions with questionable identity.  
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Third, the directed approach offers the possibility of selecting for CID 
precursor ions with specific properties. These include the charge state of a 
peptide that is most likely to yield an informative fragment ion spectrum, 
particular patterns after stable isotope labeling (13, 15, 16, 38), characteristic 
isotope distributions generated by tagging selected functional groups with 
suitable reagents (39), both isotopic version of cross-linked peptides (40) or 
redundant identification of peptides of interest over multiple samples (e.g. time 
course experiments) (13). 
 
For analyzing complex mixtures, the most important improvement of directed 
versus DDA LC-MS/MS results from the fact that the directed approach copes 
with the problem of “undersampling” during LC-MS/MS analysis meaning that 
not all precursor ions present in the MS1 scans can be sequenced using DDA 
based LC-MS/MS (8-11). This results in the preferred identification of peptides 
of high abundance (Figure 3A). Conversely, using the directed approach, the 
sequencing speed of the MS instrument used is no longer a limiting factor with 
respect to the under sampling problem virtually allowing any detectable 
peptide ion in a sample to be MS-sequenced. Indeed, a higher number of 
peptides were identified by using the inclusion list based approach with most 
having a precursor intensity five times lower than the majority of peptides 
determined by the DDA strategy. The exclusive identification of low intensity 
peptide ions by directed LC-MS/MS was particularly pronounced for MS1 
scans containing large numbers of peptide ions, clearly indicating incomplete 
sequencing by online DDA LC-MS/MS due to the limited MS-sequencing 
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speed and a more thorough sequencing of precursor ions by the directed 
approach. 
Nonetheless, the number of peptides identified by directed LC-MS/MS 
decreased rapidly with lower MS1 signal intensities. This can be ascribed to 
the fact that very low intense peaks do not reach the detection limit in all 
replicate runs, show higher mass tolerances and are consequently difficult to 
detect and to align across multiple maps. A higher dynamic range in the MS1 
scans would be desirable, however, this is limited by the loading capacity of 
the ICR cell (26, 27). Certainly, the dynamic intensity range of detected 
peptide ions can be extended by additional time-consuming sample 
fractionation steps (5, 41), which can be employed in combination with the 
directed approach. Second, and more importantly, each feature needs to be 
detected online by the MS-instrument to trigger an MS2. As shown above, 
changing the MS-detection parameters increased this number, but for a 
considerable fraction of low abundance features detected offline, no MS2 
scan was acquired. Therefore, further improvements in online monoisotopic 
peak detection of peptide derived precursor ions could definitely increase the 
number of CIDs for low abundant peptide ions.  
 
In conclusion, directed sequencing of non-redundant, high quality features 
enables the identification of a higher number of peptides with less analytical 
effort than current DDA LC-MS/MS based methods. For instance, more than 
1,600 phosphorylation sites could be identified using a single dimension 
reversed phase separation without the need for time-consuming sample pre-
fraction steps. The implemented software tools used are freely available and 
33 
 
compatible with generic, public accessible data formats and therefore 
applicable to most high performance LC-MS (MS1-level) platforms. With the 
increasing availability of reproducible high performance LC-MS/MS systems 
and its capability to identify features of interest specifically and redundantly 
over a wide intensity range, the directed approach presented here is well 
suited for in-depth and high throughput characterization of complex protein 
samples and will find wide application in future LC-MS/MS based proteome 
studies. 
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Figure legends 
Figure 1: Workflow of directed LC-MS/MS analysis. Aliquots of a complex 
peptide mixture are analyzed by LC-MS/MS and all MS1 peaks are extracted. 
Subsequently, sub-sets of features are selected and specifically sequenced 
by directed LC-MS/MS until MS/MS data is obtained for all detected features. 
(see text for details). 
 
Figure 2: Evaluation of different MS-conditions for improved feature 
sequencing. The 9,680 features extracted from the cytosolic digest from the 
D. melanogaster Kc167 cell line were split into five bins based on their 
intensity, each containing around 2,000 masses and subjected to directed LC-
MS/MS using a LTQ-FT MS. The percentage of (A) sequenced and (B) 
identified features in each experiment using different MS-parameters is 
shown. (C) Parallel acquisition of a high resolution MS1 scan in the ICR cell at 
a resolution of 100,000 and three MS2 spectra in the LTQ in Preview ON 
mode. (D) Sequential MS1 and MS2 data acquisition using a lower resolution 
in the ICR cell (50,000) in Preview OFF mode. The time required for each MS 
cycle is indicated. Additional experiments for features with low and very low 
intensity were performed using Preview OFF mode and disabling 
monoisotopic precursor selection (Preview + MPS OFF).  
 
Figure 3: Comparison of data dependent and directed LC-MS/MS 
analysis. (A) Unique peptides identifications of the cytosolic digest from the 
D. melanogaster Kc167 cell line obtained with multiple data dependent LC-
MS/MS experiments (DDA, blue line), optimized directed approach described 
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in Figure 2 (INL, orange line) and a combination of both methods (Combined, 
green line). Here, two DDA LC-MS/MS experiments were carried out and only 
extracted features without MS2 data subjected to two additional directed LC-
MS/MS analyses. (B) Base peak intensity distribution of the peptide precursor 
ions identified using either DDA mode (DDA, blue line) or the combined 
approach shown in A (Combined, green line). The abundance profile of the 
peptides exclusively detected with the two directed LC-MS/MS runs in the 
combined approach is also indicated (INL (from combined), red line).  
 
Figure 4: Determination of two phosphorylation sites in ATP-dependent 
Helicase SWR1 (Gene name: CG5899) by directed LC-MS/MS. (A) MS-
spectrum showing the feature selected for sequencing during directed LC-
MS/MS data acquisition. (B) Fragmentation pattern (MS/MS-spectrum) 
obtained by collision-induced dissociation of the phosphopeptide precursor 
indicated in A. The sequence of the identified phosphopeptide, including the 
two phosphorylated serine residues (pS), is shown. Fragmentation of the 
peptide backbone during tandem mass analysis would result in the 
characteristic b- and y-ions displayed. All detected fragment ions (bold) 
including loss of phosphoric acid (*) are indicated.  
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Supplementary Figure Legends 
Figure S1: Mass and elution time reproducibility during LC-MS analysis. 
(A-C) Base peak chromatograms obtained from three repetitive LC-MS 
analyses of aliquots of a cytosolic digest from the D. melanogaster Kc167 cell 
line. The retention times of the highest peaks are indicated. (D-F) 
Representative MS1 scan acquired in the ICR cell at a resolution of 100,000 
FWHM (at 400 m/z) showing several features detected at a retention time of 
50.41 min in each LC-MS run (A-C). 
 
Figure S2: Reproducibility and robustness of directed feature 
sequencing. An inclusion list comprising 200 identified features from each of 
the five intensity groups shown in Figure 2B was generated and re-analyzed 
five times by directed LC-MS/MS. (A) Number of times a features was 
sequenced or identified in the five replicates. (B) Number of features 
sequenced and identified in all five replicate runs based on their intensity. 
 
Figure S3: Non-redundant, directed LC-MS/MS analysis of a 
phosphopeptides mixture. A cytosolic digest from the D. melanogaster 
Kc167 cell line enriched for phosphopeptides using TiO2 affinity 
chromatography was analyzed by the combined directed approach shown in 
Figure 3A. The first two LC-MS/MS runs (1 (DDA 2+) and 2 (DDA >2+) were 
performed in DDA mode, allowing only doubly or triply and higher charged 
peptide ions, respectively, to trigger MS2 scans. Extracted features obtained 
from these to runs without MS2 data were subjected to two additional directed 
LC-MS/MS runs (3 (INL-1) and 4 (INL-2)). In run 5 (INL-NL), only precursor 
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ions that showed a neutral loss peak in the acquired MS2 spectra but could 
not be confidently assigned to a peptide sequence were re-sequenced with 
enabled multi stage activation mode in the LTQ-FT MS. The total number of 
identified peptides, phosphopeptides and phosphorylation sites together with 
the number of LC-MS/MS runs carried out is indicated. 
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Table 1: Reproducibility of directed LC-MS/MS
*) Feature intensity bins based on feature area determined by SuperHirn (very high: 2.6x109 – 3x107, high: 3.0 – 1.4x107, medium: 
1.4x107 - 8.1x106, low: 8.1 – 4.9x106, very low: 4.9x106 – 5.3x105)  
**) The same 1000 features were targeted in each run, including 200 features of each intensity bin
# of 
observations
Feature 
Intensity*
# of features 
targeted**
# of features 
sequenced
# of features 
identified
1 All 1000 984 945
2 All 1000 972 906
3 All 1000 953 863
4 All 1000 923 803
5 All 1000 865 695
5 Very high 200 200 192
5 High 200 186 164
5 Medium 200 170 129
5 Low 200 161 117
5 Very low 200 148 93
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Table 2: Identified phosphopeptides using directed LC-MS/MS
*) Run 1 (DDA 2+) and 2 (DDA >2+): only doubly or higher charges peptide ions, respectively, were allowed to trigger CID by D DA. Run 3 (INL-1) and 4 (INL-2): directed 
LC-MS/MS of un-sequenced features extracted from run 1 and 2. Run 5 (INL-NL): directed LC-MS/MS of unassigned neutral loss showing precursors
**) Numbers calculated from Bioworks 3.2 search results using an in-house software tool (25)
LC-MS/MS 
run*
# of peptides 
identified**
# of phosphopeptides 
identified**
# of phosphorylation 
sites identified**
% of phosphopeptides 
identified**
1 (DDA 2+) 742 655 678 88.27
2 (DDA >2+) 1085 949 997 87.47
3 (INL-1) 1439 1254 1347 87.14
4 (INL-2) 1621 1405 1521 86.67
5 (INL-NL) 1721 1500 1628 87.16
41 
 
 
Table 3: Identified phosphorylation sites involved in the Wnt-signaling pathway
*) Accession number as indicated in Flybase 4.3
**) Run 1 (DDA 2+) and 2 (DDA >2+): only doubly or higher charges peptide ions, respectively, were allowed to trigger CID by DDA. Run 3 (INL-1) and 4 (INL-2): directed 
LC-MS/MS of un-sequenced features extracted from run 1 and 2. Run 5 (INL-NL): directed LC-MS/MS of unassigned neutral loss showing precursors
***) Search result values obtained from Bioworks 3.2
Accession 
number*
Gene 
name
LC-MS/MS run 
detected**
Precursor 
mass (Da)
Charge 
state
Peptide Propability***
Sf-
score***
Xcorr***
delta 
CN***
FBgn0001139 gro 1 (DDA 2+) 1182.51506 2 R.NSVS*PADREK.Y 1.83E-03 0.85 3.26 0.31
FBgn0001139 gro 1 (DDA 2+) 1356.67538 2 R.TRS*PLDIENDSK.R 1.52E-06 0.82 3.28 0.43
FBgn0002783 mor 1 (DDA 2+) 1520.71046 2 K.ANAALQSTAS*PAPGGK.S 1.03E-03 0.70 3.34 0.05
FBgn0015805 Rpd3 1 (DDA 2+) 2141.75841 2 R.IVPENEYS*DS*EDEGEGGR.R 2.53E-05 0.95 6.44 0.09
FBgn0015805 Rpd3 1 (DDA 2+) 2297.85952 2 R.IVPENEYS*DS*EDEGEGGRR.D 2.41E-04 0.56 4.65 0.14
FBgn0022131 aPKC 2 (DDA >2+) 2845.32267 3 K.EGIRPGDTTS*TFCGTPNYIAPEILR.G 1.20E-03 0.53 4.04 0.30
FBgn0003371 sgg 2 (DDA >2+) 1852.84120 3 K.QLLHGEPNVSY* ICSR.Y 2.23E-03 0.84 4.09 0.08
FBgn0003371 sgg 3 (INL-1) 1020.40338 2 R.TSS*FAEGNK.Q 8.72E-03 0.55 1.92 0.29
FBgn0032157 CG5899 3 (INL-1) 3177.56749 3 K.LLTTALGLDKDQEEQLNNSLNNSIAS*PAK 2.19E-05 0.93 6.92 0.17
FBgn0032157 CG5899 4 (INL-2) 1981.62937 2 K.DQVYDS*DDS*DSEMSTK.M 2.29E-04 0.95 5.60 0.09
FBgn0015589 Apc 4 (INL-2) 2738.39852 3 R.RNS*VAGSGQNVDSPPVVIPASLQPLR.S 2.30E-04 0.53 3.82 0.09
FBgn0027492 wdb 5 (INL-NL) 2007.98993 2 R.YRNS*QDVELQQLPPLK.A 4.46E-03 0.90 4.45 0.15
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